Derivation Web

source_ee4e3894c72a4b39

by researka:v2 · 2026-06-13 21:20:37.685640+04:00

{"contradictions": ["Positive study-level signals are not the dominant direction in any outcome class; null signals are summarized in the contextual adjacent evidence, cardiometabolic, dosing and pharmacokinetics, and skeletal, fracture, and bone outcome classes; negative signals are not the dominant direction in any outcome class; mixed or heterogeneous signals are summarized in the muscle function and immune outcome classes. The paper therefore interprets the corpus as a tiered evidence profile rather than as a single pooled effect.", "The conclusion is that Aerobic exercise remains a bounded geroscience case: the retained clinical and adjacent evidence profile defines the scope for targeted testing, while mixed and null findings limit any unqualified anti-aging claim.", "The human randomized evidence base for Aerobic exercise in the present synthesis is broad in scope and heterogeneous in design, which is both a strength and a complication. Translational relevance to humans remains uncertain. Endpoints are similarly diverse: cardiorespiratory fitness measured as peak oxygen uptake, body-fat percentage, inflammatory biomarkers such as C-reactive protein, cognitive and executive-function batteries, neuroimaging-derived connectivity indices, vascular measures including arterial stiffness, and behavioral outcomes such as drug craving. This heterogeneity is, in part, the point — the geroscience framing demands that multiple aging-relevant outcomes be assessed in parallel — but it also makes any simple summary of Aerobic exercise's effects across studies inherently fragile, and motivates the structured cross-outcome synthesis that this paper undertakes.", "Within this evidence base, several unresolved questions stand out, and they cut across the mechanistic, clinical, and population dimensions of the Aerobic exercise case. The first concerns the translation problem: the field has collected a sizable mechanistic literature suggesting that Aerobic exercise engages hallmarks of aging — mitochondrial function, inflammation, vascular health, neuroplasticity — but the mapping from those mechanistic signals to hard clinical endpoints remains incomplete, and a general caution that surrogate associations do not guarantee hard-outcome validity (Ioannidis 2005) applies here as much as in any drug-development program. The second concerns tradeoffs and ceiling effects: typical attrition in long-duration trials of older adults can approach 20% (Schulz 2010), some cardiometabolic augmentation strategies appear to add hemodynamic and vascular benefit without further improving cardiorespiratory fitness, glucose, lipids, or inflammation (Steward 2025), and dose-response relationships between Aerobic exercise intensity, duration, and outcomes are not well characterized across the included studies. The third concerns the boundary conditions of the comparison condition: when Aerobic exercise is contrasted with no intervention, stretching and toning, or low-intensity hospital-based programs, effect sizes and significance patterns shift, raising real questions about how much of the observed benefit is Aerobic exercise-specific versus a generic effect of structured activity. These unresolved questions are not reasons to dismiss the Aerobic exercise case, but they are the reasons a careful synthesis is needed.", "This paper takes a structured-evidence approach to making sense of the Aerobic exercise literature as it currently stands, with the explicit goal of distinguishing robust signals from artifacts of design heterogeneity. The contribution is organized around three analytical moves. First, we surface the cross-outcome tensions — 148 non-orthogonal pairwise disagreements, null-versus-positive contrasts, and agreements — that exist across the included study set, and we ask whether these tensions localize to specific outcome classes, populations, or intervention parameters rather than being uniformly distributed noise. Second, we apply structured evidence weighting that separates clinical and functional outcomes (e.g., cardiorespiratory fitness, muscle function, inflammatory biomarkers) from mechanistic and contextual outcomes (e.g., neuroimaging connectivity, executive-function battery scores, behavioral correlates), and we ask whether each tier independently supports a geroprotective interpretation of Aerobic exercise. Third, we attempt to separate the question of whether Aerobic exercise modifies measurable aging-relevant biology — for which the mechanistic case is reasonably strong — from the harder question of whether those modifications translate into durable, clinically meaningful anti-aging benefit in humans, for which the current RCT evidence remains incomplete. Throughout, we maintain the framing that Aerobic exercise is a candidate with genuine mechanistic plausibility and population-scale accessibility, but with a clinical evidence base that is not yet adequate to declare victory, and with boundary conditions — dose, population, comparator, duration — that have been insufficiently characterized. The remainder of the synthesis develops this argument outcome by outcome, makes explicit the tensions and agreements identified in the curated set, and concludes with the specific trials, populations, and design features that would be most informative for the next generation of Aerobic exercise anti-aging research.", "Preclinical and disease-model data provide the principal mechanistic scaffolding for Aerobic exercise effects, and the curated evidence base touches on several of the canonical pathways invoked in geroscience. Tanaka 2012 added an 8-week intermittent, moderate-intensity protocol in healthy young subjects with reductions in arterial stiffness parameter β and pressure-strain elastic modulus E_p (P < 0.01 and P < 0.05 respectively), consistent with vascular-aging modification. The source set does not, however, support a fully specified causal chain from Aerobic exercise dose to hallmark reversal, and the mechanistic narratives can be interpreted as plausibility scaffolding rather than confirmed pathway maps.", "The within-corpus tensions on cardiometabolic endpoints are pronounced and warrant explicit discussion. Huang 2025's null direction conflicts with Elsayed 2023's positive direction (severity 3), and Huang 2025 also conflicts with Steward 2025's negative direction (severity 3). Donath 2017's null reliability framing agrees with Huang 2025's null aggregate framing (severity 1) but disagrees with Elsayed 2023's positive direction (severity 3) and with Steward 2025's negative direction (severity 3). These six cross-study disagreements, summarized in the Cross-Domain Synthesis, indicate that the cardiometabolic case for aerobic exercise as currently constituted is incomplete: positive signals in obese-senior RCTs coexist with null or negative signals in middle-aged and sedentary populations, and the boundary conditions — co-intervention type, population adiposity, and acute versus chronic exposure — remain to be established.", "The principal evidence base for immune outcomes in the corpus is anchored by a systematic review with meta-analysis of randomized controlled trials examining the effect of aerobic exercise on inflammatory markers in healthy middle-aged and older adults (Zheng 2019). The synthesis aggregated trials of aerobic training interventions in this population and quantified pooled effects on canonical inflammation biomarkers, including C-reactive protein (CRP) and additional cytokines measured across the included studies. The meta-analytic framework permits attribution of effect direction and statistical significance at the pooled rather than per-study level, which is the unit relevant to this synthesis.", "Quantitatively, the pooled analyses yielded effect-direction calls of mixed across the inflammatory endpoints examined, indicating that the direction of change was not uniform across markers (Zheng 2019). The reported p-values from the pooled comparisons — P = 0.0002, P = 0.0007 (appearing twice in the source), P = 0.0002, P = 0.0007, and P = 0.003 — establish that several of these pooled comparisons reached conventional statistical significance, while the overall effect direction is recorded as mixed, consistent with the possibility that some markers moved favorably, others less so, or that the pooled estimate was attenuated by inter-study heterogeneity. Per-study p-values and confidence intervals are catalogued in the supplementary evidence tables rather than restated here.", "Mechanistically, the inflammatory-marker findings are coherent with the broader corpus pathways linking aerobic exercise to immune modulation through reductions in systemic low-grade inflammation, a substrate implicated in age-related functional decline (Zheng 2019). Because Zheng 2019 is a meta-analysis of human RCTs, the evidence it contributes sits at the clinical RCT tier of the mechanistic spectrum; the human RCT tier is the highest level of causal inference represented in the immune outcome class within the corpus. The review-graded directness label reflects that this is a synthesis of primary trials rather than a single mechanistic study, and the canonical trial id field is recorded as none because no individual trial identifier was extracted from the source."], "limitations": ["This is an agent-assisted evidence map, not a PRISMA-complete systematic review or clinical guideline.", "It is not PROSPERO-registered and should not be read as medical advice.", "Public sidecars expose citation traces and extraction status; empty fields mean not extracted, not assumed absent."], "publication_id": "686181b7-a4b3-4dd3-8ae9-e1e44b2813fc", "screening": {"excluded": 0, "exclusion_reasons": ["No PRISMA full-text exclusion-stage filter was applied."], "flow": ["identified", "screened", "excluded_with_reasons", "included"], "identified": 42, "included": 42, "included_or_retained": 42, "screened": 42, "wording": "42 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit."}}

{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "686181b7-a4b3-4dd3-8ae9-e1e44b2813fc",
  "researka_submission_id": "274989cd-4e9e-4709-92a4-5b904eefe498",
  "sidecar_name": "contradiction_map.json",
  "sidecar_url": "https://api.researka.org/publications/686181b7-a4b3-4dd3-8ae9-e1e44b2813fc/sidecars/contradiction_map.json"
}